•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student
other

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences
An estimated 0-minute read

Rajani Associates, advices Nectar Lifesciences Limited in relation to PE investment by New Silk Route

 Email  Facebook  Tweet  Linked-in

Rajani Associates, a Mumbai based law firm has concluded private equity deal whereby New Silk Route has invested in Nectar Lifesciences Limited, listed on the Bombay Stock Exchange and the National Stock Exchange.

 

Nectar Lifesciences Limited a fast growing pharmaceutical company with ambitious plans to become market leader in the segment, also, intending to scale its share in $35-billion healthcare industry which would be touching $75 billion by 2012.

 

A fast track private equity deal in the listed entity was approx. USD 20 million fetching NSR Direct PE Mauritius LLC a significant minority stake in Nectar Lifesciences Limited.

 

Rajani Associate has advised the Company while Desai & Diwanji had advised the NSR Direct PE Mauritius LLC  on structuring and negotiating the transaction on a time crunched private equity transaction to make it a win-win deal for all the parties with fast, focused and effective strategy.

Click to show 4 comments
at your own risk
(alt+c)
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.